P049 Investigation into the binding affinity of certolizumab pegol to FcRn and functional consequences for FcRn-mediated transcytosis: comparison to infliximab, adalimumab and etanercept

Autor:	Andrew Nesbitt, Lara Kevorkian, Terry Baker
Rok vydání:	2014
Předmět:	Transcytosis business.industry Gastroenterology Adalimumab Medicine General Medicine Pharmacology Certolizumab pegol business Infliximab Etanercept medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 8:S83-S84
ISSN:	1873-9946
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b582eccbb48aa6d0c9989e8553cd534f https://doi.org/10.1016/s1873-9946(14)60171-9 Zobrazit plný text záznamu